Literature DB >> 34114190

Response to "Comment on: Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety".

Young R Lee1.   

Abstract

Entities:  

Year:  2021        PMID: 34114190     DOI: 10.1007/s40261-021-01050-5

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


× No keyword cloud information.

北京卡尤迪生物科技股份有限公司 © 2022-2023.